Literature DB >> 23567463

Therapy: real-world trial of treat-to-target--less drop-out, shorter time to improvement.

Emma Leah.   

Abstract

Year:  2013        PMID： 23567463     DOI： 10.1038/nrrheum.2013.54

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Treating to a target in established active rheumatoid arthritis patients receiving a tumor necrosis factor inhibitor: results from a real-world cluster-randomized adalimumab trial.

Authors:  Janet E Pope; Boulos Haraoui; Emmanouil Rampakakis; Eliofotisti Psaradellis; Carter Thorne; John S Sampalis
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-09       Impact factor: 4.794
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.